Top news of the week: 03.03.2020.
#lifesciences #pharma #biotech #biospace #BIO2020 #savetheplanet #environment #Biopharma #climatechange #plasticfree
Companies And Industries
Something Ventured: Vor Biopharma and 3 other startups got venture funding a year ago. Did it help... https://t.co/zM6EVdDIZG via @statnews
OpenSomething Ventured: Vor Biopharma and 3 other startups got venture funding a year ago. Did it help them do what they said it would?
Vor Biopharma, Tiburio Therapeutics, Apic Bio, and Ribon Therapeutics got venture funding last year. Did it help them do what they said it would?
#Migraine Market: #Biopharma Companies Working Toward Treatments
#biospace #lifesciences #biotech #pharma
https://t.co/ogPERLAL9f
OpenMigraine Market: Biopharma Companies Working Toward Treatments
BioSpace takes a look at some of the investigational products that could, one day, provide relief for migraine sufferers.
We Have a Plastic Problem; Can Biotech Fix It? https://t.co/BDrhH7b0eM
#environment #plasticfree #savetheplanet #climatechange https://t.co/JYXnCR9ZXm
OpenWe Have a Plastic Problem; Can Biotech Fix It?
Since 1979, we’ve been digging our planet’s grave and filling it with plastic. Half of the 300 million tons of plastic produced worldwide each year are single-use plastic. Meaning it gets ...
China’s BrightGene Bio-Medical Technology has been censured by the Shanghai Stock Exchange for wrongly claiming it is able to manufacture Gilead’s experimental #coronavirus drug remdesivir https://t.co/dJeQh21hvC
OpenChinese biotech censured for misleading coronavirus drug claims
China’s BrightGene Bio-Medical Technology has been censured by the Shanghai Stock Exchange for wrongly claiming it is able to manufacture Gilead’s experimental drug remdesivir – scientists’ ...
RT @IAmBiotech: 🆓 Enter to Win a Free #BIO2020 Company Presentation and Registration https://t.co/YKRqJswvMm 🆓 https://t.co/feKbvnHcfm
OpenEnter to Win a Free BIO 2020 Company Presentation and Registration
Are you an innovative biotech company that is R&D-intensive and is developing strategic partnerships within the industry? Enter the Buzz of BIO Contest for your chance to win a ...
Takeda buys PvP Biologics for $330m, adds potential #coeliac drug to its pipeline https://t.co/RKBbFKdi9e @TakedaPharma
OpenTakeda buys US biotech PvP Biologics for $330 million
Takeda has bought US biotech PvP Biologics for $330 million, adding a potential new form of therapy for coeliac disease to its pipeline.
How a #Neurobiologist and a Biotech Manager Turned Their Passion for Science into #Teaching
#biospace #lifesciences #biotech #pharma
https://t.co/DcvBbjsCl7
OpenSponsored | How a Neurobiologist and a Biotech Manager Turned Their Passion for Science into Teaching
A look at how two biotech professionals made the transition from research to inspiring students as biotech teachers with the help of EnCorps STEM Teachers Program.
Coronavirus outbreak brings focus on companies developing potential therapies https://t.co/buv4XIG0tH
OpenCoronavirus outbreak brings focus on companies developing potential therapies
The public attention that COVID-19 has received has spilled over to antibiotics companies, and the BioWorld Infectious Diseases index has grown 14% in value since the beginning of the year.